FindTrial
Sign In

Triglyceride-lowering effect of DHA/EPA intake : Systematic Review

A systematic review of the triglyceride-lowering effects of DHA/EPA in healthy individuals, including those with high triglyceride or LDL cholesterol(blood lipids) levels - A systematic review of the triglyceride-lowering effects of DHA and EPA in healthy subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000058094
Enrollment
Unknown
Registered
2025-06-09
Start date
2025-06-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

None listed

Sponsors

Sankyo Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Clinical trials under the following PICOS criteria: ?? : Healthy adults, including those with mild dyslipidemia ?? : Oral intake of foods containing DHA/EPA ?? : Oral intake of placebo foods ?? : Serum triglyceride levels ?? : Randomized, placebo-controlled trials 2) Original articles published in peer-reviewed journals

Exclusion criteria

Exclusion criteria: 1) trials include participants with serum triglyceride levels of 200 mg/dL or greater, or LDL cholesterol levels of 160 mg/dL or greater. 2) trials in which factors other than DHA/EPA intake may have influenced the outcomes

Design outcomes

Primary

MeasureTime frame
Triglyceride level—

Countries

Japan

Contacts

Public ContactDaisuke Hagiuda

Sankyo Co.,Ltd. Scientific affairs Dept.

hagiuda-d@sankyocoltd.co.jp0545-54-1248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026